The Intestinal Bug Hypothesis in Crohn's Disease Gets a Reboot
The Economic Costs of Crohn's Disease
Exploring the Intersection of Chronic Disease, Adherence, and Life Expectancy
Recurrence of Breast Cancer Years After the Initial Tumor
Upending of Conventional Combination Therapy in Type 2 Diabetes Mellitus
Breast Cancer Survivorship Programs: More Than a Treatment
Robotic-Assisted Surgery: A Question of Value
Can Gastric Bypass Surgery Be a Cure for Diabetes Mellitus?
Inhaled Insulin's Long Journey to Commercialization
A Patient's Opinion of Unmet Need
The How and Why of Stress, Diabetes, and the Brain
A Visit With Mark Feinglos, MD, and Richard Surwit, PhD
Increasing Access to HIV Care May Help Improve Outcomes
Targeted Programmed Cell Death in Lung Cancer Treatment
The Link Between a Common Type of Bariatric Surgery and Increased Alcohol Use
The Continuing Evolution of Employer-Based Intervention in Diabetes Disease Management
What Is the Place of New SGLT-2 Inhibitors in Therapy and on the Formulary?
Is Medicare Ready for Oncology Clinical Pathways?
Attacking Complications to Kidney Problems in Diabetes: Atrial Fibrillation and Resistant Hypertension
Nonincretin Drugs in Later-Stage Development
New Approaches to Medicaid Expansion: Hybrid Plans Offer Alternatives for Covering More People
The Next Frontier for the Artificial Pancreas: Payer Coverage
Sequester Forcing Chemo Treatments into Hospitals Costing Taxpayers More in the End
BMI and Beyond: Identifing Obesity in Patients at Risk for Diabetes and Heart Disease
Innovations on the Horizon for the Treatment of Type 2 Diabetes An Interview With Javier Morales, MD
Searching for Clinical and Economic Value in Pancreatic Cancer
Chemoprevention in Prostate Cancer: Identifying Patients at Greatest Risk May Provide Greatest Value
Applying Accountable Care to Oncology: Developing an Oncology ACO
The cost-saving potential of specialty or disease-specific ACOs can be huge...but it is unclear whether these specialty services are more efficiently provided through their own ACO or as ancillary to the burgeoning primary care ACO marketplace.
Value-Based Contracting for Pharmaceuticals: Getting Ready for Prime Time?
Is There a Business Case for Diabetes Disease Management?
The Complexity of Covering Off-Label Use for a Multitude of Oncology Regimens
2 Clarke Drive Cranbury, NJ 08512